Rep. Tim Moore Purchases Shares of Centene Corporation (NYSE:CNC)

Key Points

• Representative Tim Moore recently purchased shares of Centene Corporation (NYSE:CNC), investing between $15,001 and $50,000 on July 29th.
• Centene reported a net loss of ($0.16) earnings per share for the last quarter, falling short of analysts' expectations, despite achieving a revenue of $48.74 billion.
• Wall Street analysts have downgraded Centene's stock, with several firms reducing their price targets significantly, reflecting a cautious outlook on the company's performance.

Representative Tim Moore (R-North Carolina) recently bought shares of Centene Corporation NYSE: CNC. In a filing disclosed on August 05th, the Representative disclosed that they had bought between $15,001 and $50,000 in Centene stock on July 29th.

Representative Tim Moore also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Harley-Davidson NYSE: HOG on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Verizon Communications NYSE: VZ on 7/29/2025.
• Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Centene NYSE: CNC on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 7/21/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/21/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/18/2025.

Centene Stock Performance

CNC traded up $0.32 during trading on Friday, hitting $25.58. The stock had a trading volume of 11,416,944 shares, compared to its average volume of 22,123,356. The company has a 50 day simple moving average of $40.30 and a 200-day simple moving average of $53.31. Centene Corporation has a 12 month low of $25.08 and a 12 month high of $80.59. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. The firm has a market cap of $12.56 billion, a PE ratio of 6.33, a P/E/G ratio of 1.03 and a beta of 0.40.

Centene (NYSE:CNC - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.39). The business had revenue of $48.74 billion for the quarter, compared to analyst estimates of $44.71 billion. Centene had a net margin of 1.15% and a return on equity of 9.57%. Centene's revenue was up 22.4% on a year-over-year basis. During the same quarter last year, the firm posted $2.42 earnings per share. Analysts expect that Centene Corporation will post 6.86 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Robert W. Baird dropped their price target on shares of Centene from $68.00 to $28.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Oppenheimer reduced their price target on shares of Centene from $51.00 to $43.00 and set an "outperform" rating for the company in a report on Monday, July 28th. Morgan Stanley cut their price target on shares of Centene from $33.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Monday, August 4th. Cantor Fitzgerald downgraded shares of Centene from an "overweight" rating to a "neutral" rating and decreased their price objective for the company from $65.00 to $38.00 in a research report on Monday, July 28th. Finally, Truist Financial cut their target price on shares of Centene from $42.00 to $35.00 and set a "buy" rating for the company in a research note on Monday, July 28th. One investment analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Centene has an average rating of "Hold" and a consensus target price of $42.20.

Insider Buying and Selling

In other Centene news, Director Theodore R. Samuels II bought 9,000 shares of the firm's stock in a transaction dated Monday, July 28th. The stock was acquired at an average cost of $27.62 per share, for a total transaction of $248,580.00. Following the completion of the transaction, the director owned 32,000 shares in the company, valued at $883,840. This trade represents a 39.13% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.36% of the stock is owned by insiders.

Institutional Trading of Centene

Institutional investors have recently bought and sold shares of the company. Pinney & Scofield Inc. bought a new position in shares of Centene in the 4th quarter worth approximately $25,000. Ameriflex Group Inc. purchased a new stake in Centene during the 4th quarter valued at approximately $26,000. Quarry LP purchased a new position in shares of Centene in the first quarter valued at $26,000. Studio Investment Management LLC purchased a new position in shares of Centene in the fourth quarter valued at $32,000. Finally, Golden State Wealth Management LLC grew its holdings in shares of Centene by 203.1% in the first quarter. Golden State Wealth Management LLC now owns 579 shares of the company's stock valued at $35,000 after purchasing an additional 388 shares in the last quarter. 93.63% of the stock is owned by hedge funds and other institutional investors.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024. Moore served as speaker of the House from 2015 to 2025. Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.